Pharma Focus Europe

Press Releases

Our team at believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.

Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN) Tokyo 2023

Saturday, September 30, 2023

Calliditas Therapeutics AB NASDAQ CALT NASDAQ Stockholm CALTX Calliditas today announced the presentations of new biomarker and subgroup analyses from the Phase NefIgArd study with Nefecon TARPEYO budesonide delayed release capsulesKinpeygo in adult...

BioLineRx Announces Encouraging Data from Pilot Phase of Phase 2 Combination Clinical Trial with Motixafortide in First-Line Pancreatic Cancer (PDAC)

Friday, September 29, 2023

BioLineRx Ltd NASDAQ BLRX TASE BLRX a commercial stage biopharmaceutical company pursuing lifechanging therapies in oncology and rare diseases today announced encouraging data from the singlearm pilot phase of the investigatorinitiated CheMoMETPANC P...

Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors

Friday, September 29, 2023

Baudax Bio Inc the Company or Baudax Bio NASDAQ BXRX a biotechnology company focused on developing T cell receptor TCR therapies utilizing human regulatory T cells Tregs

HRH Princess Astrid of Belgium visits Telix's New European Manufacturing Facility in Brussels South

Thursday, September 28, 2023

Telix Pharmaceuticals Limited ASX TLX Telix the Company has welcomed Her Royal Highness Princess Astrid Princess of Belgium to Telix Manufacturing Solutions TMS the Companys recently inaugurated production facility in Brussels South Seneffe in the Wa...

Cosmo And Glenmark Announce The Signing Of Distribution And License Agreements For Winlevi® In Europe And South Africa

Thursday, September 28, 2023

Cosmo Pharmaceuticals NV SIX COPN XETRA C Cosmo and Glenmark Specialty SA a subsidiary of Glenmark Pharmaceuticals Ltd Glenmark today announced the signing of distribution and license agreements for Winlevi clascoterone cream in Europe and South Afr...

Calliditas Therapeutics granted orphan drug designation by the FDA for the treatment of Alport syndrome with setanaxib

Thursday, September 28, 2023

Calliditas Therapeutics AB Nasdaq CALT Nasdaq Stockholm CALTX Calliditas today announced that the US Food and Drug Administration FDA has granted orphan drug designation ODD to the company for the treatment of Alport syndrome with setanaxib

Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova

Wednesday, September 27, 2023

Repligen Corporation NASDAQRGEN a life sciences company focused on bioprocessing technology leadership today announced that it has entered into a definitive agreement to acquire privatelyheld Metenova AB Metenova of Mlndal Sweden

Sandoz receives European Commission approval for Tyruko® (natalizumab), first and only biosimilar for multiple sclerosis in Europe

Wednesday, September 27, 2023

Sandoz a global leader in generic and biosimilar medicines today announced that the European Commission EC granted marketing authorization for the first and only biosimilar Tyruko natalizumab developed by Polpharma Biologics

AbbVie Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Tuesday, September 26, 2023

AbbVie NYSE ABBV today announced that the European Commission EC has granted conditional marketing authorization for TEPKINLY epcoritamab as a monotherapy for the treatment of adult patients

Biophytis And Skyepharma Sign A Partnership Agreement For The Production Of Sarconeos (Bio101)

Tuesday, September 26, 2023

Biophytis and Skyepharma a French pharmaceutical company specializing in the formulation development and production of pharmaceutical products